Adenoviral vectors have been exploited for a wide range of gene therapy applications. Direct genetic modification of the adenovirus capsid proteins has been employed to achieve alteration of vector tropism. We have defined the carboxy-terminus of the minor capsid protein pIX as a locus capable of presenting incorporated ligands on the virus capsid surface. Thus, we sought to exploit the possibility of incorporating functional proteins at pIX. In our current study, we incorporated the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) within pIX to determine if a larger protein of this type could retain functionality in this context. Our study herein clearly demonstrates our ability to rescue viable adenoviral particles that display functional HSV-1 TK as a component of their capsid surface. DNA packaging and cytopathic effect were not affected by this genetic modification to the virus, while CAR-dependent binding was only marginally affected. Using an in vitro [ , we demonstrated that we could detect specific cell binding and uptake of adenoviral virions containing the protein IX-TK fusion protein at 1 h post-infection. Our study herein clearly demonstrates our ability to rescue viable adenoviral particles that display functional HSV-1 TK as a component of their capsid surface. The alternative display of HSV-1 TK on the capsid may offer advantages with respect to direct functional applications of this gene product. In addition, the determination of an expanded upper limit of incorporable proteins on pIX highlights its unique utility as a locus for placement of functional vector constructs. D
Introduction
Adenoviral vectors have been exploited for a wide range of gene therapy applications (Glasgow et al., 2004) . This utility derives from the unparalleled efficiency of gene transfer for both in vitro and in vivo delivery contexts (Mizuguchi and Hayakawa, 2004) . Additional advantages derive from the plasticity of the adenoviral system, which permits directed vector modification for the achievement of selected functional gains (Rots et al., 2003) . In this regard, genetic modification of the capsid proteins has been employed to achieve alteration of vector tropism for targeting purposes . In addition, selected capsid engineering steps have proved a useful means to circumvent the host anti-vector immune response directed against antigenic epitopes (Wu et al., 2002) . More recently, the incorporation of the imaging motif enhanced green fluorescent protein (EGFP) (Le et al., 2004; Meulenbroek et al., 2004) has introduced the concept that functional motifs can be incorporated within the adenoviral capsid, thereby expanding the repertoire of utilities potentially combined within a single vector particle.
The basis of this evolving paradigm stems from the recent identification of capsid locales permissive of incorporating larger and/or more complex protein moieties (Volpers and Kochanek, 2004) . In this regard, previous reports have defined clear size limits with respect to heterologous proteins incorporable at the major capsid proteins Pereboeva et al., 2004) , which effectively limited the repertoire of capsid-incorporated motifs to small linear peptides. Our more recent work has defined the carboxy-terminus of the minor capsid protein pIX as a locus capable of presenting incorporated ligands on the virus capsid surface . Of note, we have shown the pIX-incorporated EGFP is fully functional, allowing visualization of labeled viral particles for analytical purposes (Le et al., 2004) .
Based on these established feasibilities, we sought to exploit the possibility of incorporating additional functional proteins at the capsid protein pIX. In this context, herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) has been utilized both for molecular chemotherapy cancer gene therapy applications and as an agent in PET-based imaging schemas (Herschman, 2002 ). In our current study, we sought to incorporate HSV-1 TK within pIX to determine if a larger protein of this type could retain functionality in this context. Our study herein clearly demonstrates our ability to rescue viable adenoviral particles that display functional HSV-1 TK as a component of their capsid surface. The alternative display of HSV-1 TK on the capsid may offer advantages with respect to direct functional applications of this gene product. In addition, the determination of an expanded upper limit of incorporable proteins on pIX highlights its unique utility as a locus for placement of functional vector components.
Results

Construction of Ad-wt-pIX-TK
An E3-deleted adenovirus shuttle plasmid was constructed containing a pIX-TK carboxy-terminal fusion gene in place of wild-type pIX. Between the pIX and TK coding regions, we incorporated an 18 amino acid linker, SAD-DYKDDDDKLAGSGSG, containing the octapeptide DYKDDDDK FLAG-tag sequence. This shuttle plasmid was used to construct an E3-deleted adenovirus (Ad-wtpIX-TK; Fig. 1A ), which was successfully rescued. As a control, an E3-deleted adenovirus vector was constructed, which contained the TK gene replacing the E3 region, under regulation by the adenovirus early gene promoter (Ad-wt-E3-TK; Fig. 1B ). As additional controls, an E3-deleted adenovirus vector, which lacked any TK gene, was constructed (Ad-wt-dE3; Fig. 1C ), as was an E3-deleted adenovirus vector, which contained the CD gene replacing the E3 region, under regulation by the adenovirus early gene promoter (Ad-wt-E3-CD; Fig. 1D ). 
Incorporation of pIX-TK into Ad-wt-pIX-TK particles
Propagated Ad-wt-pIX-TK was purified by double CsCl ultracentrifugation where the top and bottom bands were preserved. The resulting gradient of virus was fractionated and analyzed for DNA content by absorbance at 260 nm. A major DNA content peak was present in the bottom band where mature, infectious virions normally migrate, as well as a minor peak where immature, empty virions normally migrate ( Fig. 2A) . Infectious, mature Ad-wt-pIX-TK particles were present in the bottom band as indicated by an infectivity peak in a c.p.e. assay (data not shown). The same gradient fractions of Ad-wt-pIX-TK were also analyzed with Western blots using a FLAG-tag antibody. As shown in Fig. 2B , accumulations of pIX-TK were detected in both the top and bottom band regions for Adwt-pIX-TK, confirming the co-localization of pIX-TK with the virions.
Cytopathic effect of Ad-wt-pIX-TK
To quantitatively evaluate viral cytotoxicity, survival of 911 cells after infection with Ad-wt-pIX-TK, and control Ad-wt-E3-TK and Ad-wt-dE3 viruses (at 0.01, 0.1, and 1.0 infectious units (i.f.u.)/cell), were monitored over 10 days (Fig. 3) . On days 0, 2, 4, 6, 8, and 10, the cytopathic effect of the virus was quantitated using a non-radioactive cell proliferation MTS assay. In all concentrations of virus used, Ad-wt-pIX-TK cytopathic effect on 911 cells was the same as that of both Ad-wt-E3-TK and Ad-wt-dE 3 . These findings indicate that pIX-TK incorporation did not affect the cytopathic capacity and lateralization of the virus.
CAR-dependent binding of Ad-wt-pIX-TK
The coxsackie adenovirus receptor binding ability of Adwt-pIX-TK was determined by allowing the virus to bind to cells and quantitating the bound virus with TaqMan quantitative real-time PCR (Fig. 4) . Ad-wt-pIX-TK binding to CAR (+) A549 cells was much higher than that of CAR (À) CHO cells. In addition, recombinant fiber-knob block mitigated the CAR-dependent binding of Ad-wt-pIX-TK to A549 cells. Blocking had no effect on the binding of Ad-wtpIX-TK to CHO cells. Overall, Ad-wt-pIX-TK appeared to show similar binding compared to Ad-wt-E3-TK; in addition, the CAR-dependent binding trend was very similar between Ad-wt-pIX-TK and Ad-wt-E3-TK. These results indicate that the capsid fusion protein label did not interfere with the ability of Ad-wt-pIX-TK to recognize its primary receptor CAR.
Thermostability of Ad-wt-pIX-TK
Modification of pIX may destabilize the capsid structure; comparing the thermostability of Ad-wt-pIX-TK to that of control Ad-wt-E 3 -TK assessed this possibility. Virus samples were incubated at 45 -C for various time periods and then quantitated in terms of infectious titer (Fig. 5 ). Up to 5 min of incubation, the infectious titer of Ad-wt-pIX-TK remained the same as that of control. After 5 min of incubation, the infectious titer for Ad-wt-pIX-TK and Adwt-E3-TK was about 60% and 80% of initial titers. Viral titers continued to decrease between 10 and 20 min of incubation, and the titers of Ad-wt-pIX-TK and Ad-wt-E3-TK were not significantly different from each other. These results indicate that the TK addition to pIX did not affect the thermostability of Ad-wt-pIX-TK following exposure of the virus to high temperature compared to a virus containing wild-type pIX.
GCV cytotoxicity assays
In order to determine the growth characteristics of cells treated with a pharmacologic concentration of GCV, 911 cells were initially infected with increasing doses of Ad-wt-pIX-TK ranging from 10 to 1000 v.p./cell. As controls, 911 cells were incubated with increasing doses of either Ad-wt-E3-TK or Ad-wt-E3-CD. At 12 h post-infection, the cells were incubated in the absence or presence of 1.0 mM GCV for 4 days, and cell viability was determined using an MTS assay. As anticipated (Fig. 6) , incubation of the cells with increasing doses of any of the adenoviruses resulted in a cytopathic effect in the 911 cells. Importantly, however, treatment with GCV caused an increased cytopathic effect in cells infected with either Ad-wt-pIX-TK or with Ad-wt-E3-TK. In cells infected with Ad-wt-E3-CD, however, no additional cytopathic effect was observed by the addition of GCV.
Cells infected with Ad-wt-E3-TK appeared to be more sensitive to the effect of GCV than cells infected with Adwt-pIX-TK; doses at 10 v.p./cell and at 100 v.p./cell, a greater cytopathic effect was detected in GCV-treated cells previously infected with Ad-wt-E3-TK than with Ad-wtpIX-TK. This observation could be due to a difference in TK gene expression in cells infected with Ad-wt-E3-TK compared to cells infected with Ad-wt-pIX-TK. Alternatively, this observation could be due to differences in enzymatic activity between the wild-type TK and the pIX-TK fusion protein. To differentiate between these two possibilities, real-time RT-PCR was used to assess TK RNA levels in total RNA isolated from 911 cells infected with equivalent infectious amounts of either Ad-wt-E3-TK (0.1 i.f.u./cell) or Ad-wt-pIX-TK (0.1 i.f.u./cell). The results of this assay detected an 18-fold relative increase in TK expression in cells infected for 2 days with Ad-wt-E3-TK compared to cells infected with Ad-wt-pIX-TK (data not shown).
In the experiment shown in Fig. 7 , the cells were initially infected as before for 12 h with Ad-wt-pIX-TK ranging Fig. 6 . Cell killing with increasing doses of virus in the absence or presence of GCV. A cell-killing assay was used to determine cell survival after infection with Ad-wt-E3-CD (at 10, 100, and 1000 v.p./cell), Ad-wt-E3-TK (at 10, 100, and 1000 v.p./cell), or Ad-wt-pIX-TK (at 10, 100, and 1000 v.p./cell). At 12 h postinfection, the cells were incubated in the absence or presence of 1.0 mM GCV for 4 days, and cell viability was determined using an MTS assay. The values are expressed as mean T standard deviation of three replicates. Titers for the viruses were: Ad-wt-E3-TK, 58.0 v.p./i.f.u.; Ad-wt-pIX-TK, 86.0 v.p./i.f.u.; and Adwt-E3-CD, 274 v.p./i.f.u. from 0.01 to 1.0 i.f.u./cell. As controls, 911 cells were incubated with increasing doses of either Ad-wt-E3-TK or Ad-wt-dE3. The cells were then incubated with a variety of concentrations of GCV (ranging from 0.125 to 1.0 mM) for 4 days, and cell viability was determined by MTS assay. The viability of cells infected with either Ad-wt-pIX-TK or with Ad-wt-E3-TK was inhibited at similar concentrations (ED 50 at approximately 0.5 mM). By contrast, the viability of cells infected with Ad-wt-dE3 showed no growth inhibition from any concentration of GCV. These results demonstrate that the wild-type TK and the pIX-TK fusion proteins had similar activities on growth inhibition in the presence of GCV.
HSV-1 TK enzymatic activity
HSV-1 TK enzymatic activity associated with the purified Ad-wt-pIX-TK virions was determined by monitoring the incorporation and conversion of [ 3 H]-thymidine substrate into the phosphorylated product (Fig. 8 ). In these experiments, enzymatic activity of the pIX-TK protein incorporated into virions was determined directly in vitro. As shown in 3 H]-thymidine (0.23%) at the highest amount of purified virus used. To confirm these results, at time course analysis was performed from 5 to 40 min with various amounts of purified Ad-wtpIX-TK virus. As shown in Fig. 8B , a time-dependent increase in substrate conversion was observed with hyperbolic kinetics. Together, these results demonstrate that the kinase activity of the pIX-TK fusion protein incorporated into adenoviral virions is functional.
MicroPET analysis of Ad-infected HEK293 cells
In order to determine the feasibility of using the pIX-TK fusion protein incorporated within the Ad virions as a reporter gene for microPET, Ad-wt-pIX-TK and a control Ad-wt-E3-TK were used to infect HEK293 cells. To preclude de novo protein pIX-TK synthesis, HEK293 cells were infected for only 1 h prior to microPET scanning. In the experiment shown in Fig. 9B , three 60-mm tissue culture dishes were plated 12 h previously with 1 Â 10 6 of the HEK293 cell line. On the day of microPET scanning, to each of the dishes was added 50 mCi of [
18 F]-FHBG. Immediately thereafter, to one dish was added 1 Â 10 9 v.p. of Ad-wt-pIX-TK, to a second dish was added 1 Â 10 9 v.p. of Ad-wt-dE3, and to a third dish was added virus buffer alone. The dishes were incubated for 1 h at 37 -C, followed by three washes with 5 ml of PBS. The three dishes were then stacked and placed in the microPET scanner (Fig. 9A) , and image data were acquired for 15 min. In the dish corresponding to cells infected with Ad-wt-pIX-TK, specific labeling and incorporation were observed in the region of the tissue culture dish with cell adherence (Fig. 9B) . In contrast, in the dish corresponding to cells infected with Adwt-E3-TK, only non-specific labeling was observed in the edges of the tissue culture dish; this pattern was also observed in the dish corresponding to uninfected cells. These results confirm the utility of the pIX-TK fusion protein for and form the foundation for further investigation i.f.u.) of Ad-wt-pIX-TK. Likewise at 36 h after plating, one dish was infected with an equivalent amount of Ad-wt-pIX-TK. A third dish remained uninfected. At 60 h after plating (i.e., 48 h, 24 h, and 0 h post-infection with Ad-wt-pIX-TK), 50 mCi of [ 18 F]-FHBG was added to each of the dishes. The dishes were incubated for 1 h at 37 -C, followed by three washes with 5 ml of PBS. The three dishes were then stacked and placed in the microPET scanner (Fig. 9A) , and image data were acquired for 15 min. In the dish corresponding to cells infected for 48 h with Ad-wt-pIX-TK, specific labeling and incorporation were observed in the region of the tissue culture dish with cell adherence (Fig.  9C) . Similar labeling was observed in the dish corresponding to cells infected for 24 h with Ad-wt-pIX-TK.
Importantly, in the dish corresponding to uninfected cells, no labeling was observed. These results confirm that [
18 F]-FHBG is phosphorylated intracellularly in cells infected with Ad-wt-pIX-TK.
Discussion
We have shown herein that our novel pIX-TK labeling strategy for adenoviruses only marginally affected DNA packaging and thermostability while maintaining DNA replication, viral cytopathic effect/lateralization, and CARdependent binding. Most importantly, the pIX-TK label associated with the capsid demonstrated direct TK activity in vitro in progeny virions as hypothesized. In addition, infection of cells with an adenovirus containing the pIX-TK fusion protein resulted in TK activity in cells with similar activities on growth inhibition in the presence of GCV as wild-type TK. In total, these data clearly establish the functionality of the HSV-1 TK when incorporated into the adenovirus capsid at the pIX locale.
The strategy we pursued involved the fusion of HSV-1 TK with the capsid protein pIX. The reasons for selecting this locale include: (1) its function as a minor capsid protein that is not absolutely required for replication, (2) its externally exposed carboxy-terminus to which proteins may be fused without affecting the interior of the capsid, and (3) its distant location in the hexon group of nine, which would not affect the penton base as well as the fiber-knob (Parks, 2005) . The carboxy-terminus of pIX has now been defined as a locus capable of presenting incorporated ligands on the virus capsid surface (Campos et al., 2004; Pereboeva et al., 2004; Vellinga et al., 2004) . More recently, the pIX-incorporated EGFP has been shown to be fully functional, allowing visualization of labeled viral particles for analytical purposes (Le et al., 2004; Meulenbroek et al., 2004) . The results of our current work on the pIX-TK construct mark the largest fusion protein yet achieved in the context of adenoviral capsid proteins, with the 375 amino acid TK protein sequence and an 18 amino acid linker sequence added to the carboxy-terminus of the 140 amino acid pIX protein sequence. Thus, we have expanded the upper limit to pIX fusion proteins, a size that has not yet to be defined, and may be limited only by the size of the adenoviral genome that can be incorporated into the virion capsid.
We have shown herein that the pIX-TK labeling strategy can be used to detect specific viral uptake in cells using [ 18 F]-FHBG by noninvasive imaging with microPET. One of the most sensitive paradigms for gene transfer in vivo imaging is the HSV-1 TK system (Blasberg, 2002) . TK catalyzes phosphorylation of the substrate, which becomes trapped intracellularly. With an 18 F positron emitting substitution, it is possible to determine TK substrate incorporation into cells by PET. PET is the current paradigm for sensitivity to molecular events with in vivo imaging, and animal microPET systems are now available providing greater than 1-mm resolution (Weber and Bauer, 2004) . MicroPET is ideally suited to imaging molecular events in animal studies because of its sensitivity and because the animals can be repeatedly scanned to follow the course of the disease (Luker et al., 2003) . The utility of the HSV-1 TK reporter gene technology has been demonstrated in vivo using cancer xenografts models, in which microPET and [ 18 F]-FHBG have been used to visualize and monitor tumor progression (Yaghoubi et al., 2005) . In addition, microPET offers the advantage of 3D tomographic image reconstruction over that of fluorescence or bioluminescence imaging technologies.
Preclinically, microPET has been particularly useful in monitoring extracellular receptor expression and in monitoring the efficacy of gene delivery in mouse models (Chen et al., 2004a) . This method of in vivo detection has been successfully used in mouse models. Injection of mice with an Ad vector expressing HSV-1 TK (or an empty control vector with no transgene) followed by PET imaging has shown specific accumulation of 18 F-labeled gancyclovir in the liver (the major site of infection of the recombinant adenovirus) (Chen et al., 2004b) . In contrast, injection of mice with a control vector has shown no accumulation of label in the liver. PET technology offers the unique opportunity to monitor delivery and uptake of the label in vivo and to be able to predict and modify the treatment. In oncology studies, PET provides a direct, whole body assessment of the tumor size and the pattern of distribution in normal and tumor tissues (Hustinx et al., 2002) . This is particularly important in developing human clinical trials, where the use of PET imaging using [
18 F]-fluorodeoxyglucose ([ 18 F]-FDG) is already a clinically established technique for the staging and follow-up of a wide variety of neoplasms (Alavi et al., 2004) . Recently, HSV-1 TK has been proposed as a molecular probe for assessing transgene expression in vivo and particularly for use in patients (Jacobs et al., 2001) .
While noninvasive imaging of adenoviral vector biodistribution poses formidable challenges, our genetic adenovirus pIX-TK labeling system may have an important impact in the field of adenoviral virotherapy. Virotherapy exploits the lytic property of virus replication to kill tumor cells (Ries and Brandts, 2004) . Because this approach relies on viral replication, the virus can self-amplify and spread in the tumor from an initial infection of only a few cells (Kirn, 2000) . Although early attempts were abandoned because of toxicity and inefficacy (Sinkovics and Horvath, 1993) , the virotherapy approach has reemerged with great promise, in large part, due to better understanding of virus biology and the ability to genetically modify viruses (Everts and Van der Poel, 2005) . In particular, conditionally replicative adenoviruses (CRAds) have been modified to be selective for tumor cells (Oosterhoff and van Beusechem, 2004) . The potential of CRAds to be the next cancer therapy breakthrough has been substantiated by their rapid translation into human clinical trials (Nettelbeck, 2003) . All of the initial CRAd clinical trials have validated the safety of using oncolytic adenoviruses for cancer therapy. Yet what these trials failed to ascertain and what remain to be rigorously determined are the crucial functions of CRAds: (1) selective replication and killing, (2) robustness of replication, and (3) spread of the virus.
Limited understanding of CRAd behavior is attributed to lack of a noninvasive imaging system for monitoring replicative agents. Several studies have attempted to address this problem, using reporter genes such as green fluorescent protein (GFP) (Yang et al., 2000) , SSTR-2 (somatostatin receptor type 2) (Zinn et al., 2000) , sodium iodide symporter (Cho et al., 2002) , luciferase (Bhaumik and Gambhir, 2002) , and HSV-1 TK (Liang et al., 2002) incorporated into oncolytic viruses. Detection was restricted to infected cells expressing the reporter gene, which does not truly represent the physical biodistribution of the virus itself. Conventional imaging systems for gene therapy have been designed for the detection of transgene expression of such reporters, which correlated with therapeutic outcome but could not show viral localization (Min and Gambhir, 2004) .
Despite their utility for assessing gene delivery and expression, these reporters by themselves are not suitable for monitoring CRAd activity. The essence of oncolytic virus function is to infect and kill target cells, a concept that is at odds with reporter gene expression. In addition, reporter gene expression may not truly represent the underlying level of viral replication and the physical distribution of viral progeny. No completed clinical trials so far have incorporated a monitoring component into replicative agents themselves, and therefore have had to rely on conventional histology of biopsy specimens and analysis of body fluids for the detection of virus. Such static assessments fall short of accurately depicting the dynamic mechanism of replicative agents. The ideal system for monitoring CRAds and other oncolytic viruses should provide the flexibility for dynamic detection of both viral replication and spread to yield valuable and meaningful data.
Our results confirm the utility of the pIX-TK fusion protein for and form the foundation for further investigation of [
18 F]-FHBG for noninvasive and repeated imaging of Ad-wt-pIX-TK in vivo with PET technology. To this end, our pIX-TK genetic adenovirus capsid labeling system may offer unprecedented noninvasive dynamic imaging of CRAd replication and spread. Not only may this tool be indispensable in the preclinical development of advanced generation CRAds, but it may also be practical in the clinical setting to monitor the application of these agents for cancer therapy.
We have shown herein that our novel genetic labeling strategy of a pIX-TK fusion protein resulted in TK activity in cells with similar activities on growth inhibition in the presence of GCV as wild-type TK. One of the most promising cancer gene therapy systems involves the use of suicide gene therapy. At present, many experimental suicide gene therapy approaches using the HSV-1 TK suicide gene therapy model are in clinical trials (Fillat et al., 2003) . The HSV-1 TK enzyme is the target of drugs such as acyclovir (ACV) and gancyclovir (GCV). Only cells expressing the HSV-1 TK enzyme produce the monophosphate form of these drugs. The monophosphate is subsequently converted to the highly toxic triphosphate form, which causes inhibition of cellular DNA polymerase and additional genotoxic effects through incorporation into DNA. In the absence of the drug, constitutive expression of the HSV-1 TK gene is not harmful: TK-transduced cells grow normally both in vitro and in vivo. In fact, transgenic mice expressing the HSV-1 TK gene have been produced with no toxicity in the absence of GCV (Tian et al., 2003) .
In vitro, cells expressing the Ad-wt-pIX-TK construct were maximally inhibited by GCV in the 0.5 mM range, a level that is readily achieved in patients treated with the drug. These results suggest that suicide gene therapy may represent an attractive adjuvant therapeutic approach using adenoviral vectors modified with a pIX-TK fusion protein and may enhance cell killing using the adenoviral virotherapy approach. A potential advantage of combining the suicide gene therapy approach is that even when less than 100% of the tumor is genetically modified, the entire tumor mass can be eradicated through the ''bystander effect'' of TK/GCV gene therapy (van Dillen et al., 2002) . Thus, the combination of suicide gene therapy and virotherapy may provide an additional benefit for the pIX-TK fusion protein, together with in vivo imaging by microPET.
Materials and methods
Cell culture
Human embryonic kidney epithelial (HEK293) cells, Chinese hamster ovary (CHO), and human lung adenocarcinoma A549 cells were obtained from and cultured in the medium recommended by the American Type Culture Collection (Manassas, VA). The adenovirus helper cell line 911 (Fallaux et al., 1996) was grown in DMEM supplemented with 10% FBS, 100 IU/mL penicillin, 100 Ag/mL streptomycin, and 2 mM l-glutamine. All cell lines were incubated at 37 -C and 5% CO 2 under humidified conditions.
Recombinant adenovirus construction
All viruses were constructed by homologous recombination in Escherichia coli using methods previously described (He et al., 1998) , using The HSV-1 TK gene from PDC.SSTR.HSV-tk (Zinn et al., 2002) was cut with SalI digestion (and blunt-ended by Klenow filling) followed by BglII digestion. The excised HSV-1 TK fragment was inserted into an E3-deleted shuttle plasmid pShuttleE3 after digestion with KpnI (and blunt-ended by Klenow filling) and with BamHI to generate pShuttle-E3-HSV1-tk. Homologous recombination was performed with plasmid PTG3602 (containing the wild-type E1, E3 Ad5 backbone) and the resultant recombinant plasmid was linearized with PacI and transfected into 911 cells to generate the Ad-wt-E3-TK control virus. To construct the Ad-wt-pIX-TK virus, the HSV-1 TK gene was inserted in-frame at the carboxyl terminus of the adenovirus protein IX gene (NheI site) within pShuttle.wt.E1-IX-flag (Le et al., 2004) after an 18 amino acid linker, SADDYKDDDDKLAGSGSG, containing the octapeptide DYKDDDDK FLAG-tag sequence. Homologous recombination was performed with the resulting pShuttle.wt.E1-pIX-flag-TK and with plasmid PTG3602AmpF2dE3 (containing the E1, E3 deleted Ad5 backbone) and the resultant recombinant plasmid was linearized with PacI and transfected into 911 cells to generate the Ad-wt-pIX-TK virus.
Virus propagation and purification
Viruses were propagated in 911 cells and HEK293 cells, which do not express wild-type pIX. Viruses were purified by double CsCl ultracentrifugation and dialyzed against phosphate-buffered saline with Mg 2+ , Ca 2+ , and 10% glycerol.
Final aliquots of virus were analyzed for viral particle titer (using absorbance at 260 nm) and infectious units (using a plaque forming assay). Viruses were stored at À80 -C until use. Final Characterization of virus gradient fractions (Western blot and DNA content assay)
After double CsCl ultracentrifugation which was retained through yielding one tube from ten 150-mm tissue culture dishes, the top and bottom bands were collected from the bottom of tube by two drops each sample (¨100 Al). Fractionated samples (10 Al) were ethanol precipitated, pelleted, and resuspended with 20 Al RIPA buffer. Samples (10 Al) were resolved with 10% SDS -PAGE and transferred to a PVDF membrane (BioRad, Hercules, CA). Blotting was performed with a primary monoclonal FLAG antibody (1:2000 dilution, SIGMA, F3165) followed by a secondary HRP-linked anti-mouse antibody (1:5000 dilution, Amersham Pharmacia, Piscataway, NJ). Bands were detected using a chemiluminescent ECL kit (Amersham Pharmacia). DNA content was determined by measuring the absorbance at 260 nm (MBA 2000, Perkin-Elmer, Shelton, CT).
Cytopathic effect assay
Five thousand 911 cells were infected with Ad-wt-dE3, Ad-wt-E3-TK, and Ad-wt-pIX-TK (1.0, 0.1, and 0.01 i.f.u./ cell) in 100 Al of 5% DMEM medium without phenol red in 96-well plates (six replicates each plus six non-infected cells as control). Cytopathic effect was measured by MTS assay (Promega, Madison, WI) at 0, 2, 4, 6, 8, and 10 days postinfection. Results were calculated as percent of non-infected cells with blank values (medium only) subtracted.
Thermostability assay
Twenty thousand 911 cells were subcultured overnight into 48-well plates with 150 Al DMEM medium containing 5% FBS. Prior to infection, the viruses were incubated for 0-, 5-, 10-, 20-, and 40-min time periods at 45 -C, and subsequently, the heat-treated viruses were used to infect the 911 cells (at a multiplicity of infection of 0.1 i.f.u. units/ cell). At 24 h post-infection, the cells were collected for total DNA preparation, and viral replication was determined using TaqMan real-time PCR of adenovirus E4 DNA. Genomic DNA from the cells was isolated and cleaned using a Qiagen Tissue Kit (Qiagen), following the instructions of the manufacturer. The concentration of isolated DNA was determined by spectrophotometry. TaqMan primers and probe design, the forward primer, the reverse primer, and the 6-carboxyfluorescein-labeled probe to amplify the E4 gene were designed by the Primer Express 1.0 software (Perkin-Elmer, Foster City, CA) following the recommendations of the manufacturer. The sequences of the forward and the reverse E4 primers were 5V-GGAGTGCGCCGAGA-CAAC-3V(annealing between residues 816 and 833 of the E4 orf6 open reading frame) and 5V-ACTACGTCCGGCGTTC-CAT-3V (annealing between residues 883 and 865), respectively. The sequence of the TaqMan probe was 5V-TGGCATGACACTACGACCAACACGATCT-3V (anneals between residues 836 and 863). The HSV-1 TK primer pairs (forward, 5V-GCACGTCTTTATCCTGGATTACG-3V and reverse, 5V-TGGATCATCCCGGAGGTAAG-3V) and probe (5V-CCGGGACGCCCTGCTGCA-3V) were selected to be unique and non-homologous to any known human sequence. The probes were labeled with a reporter fluorescent dye FAM (6-carboxyfluorescein) at the 5V end and a quencherfluorescent dye TAMRA (6-carboxy-tetramethylrhodamine) at the 3Vend.
With optimized concentration of primers and probe, the components of real-time PCR mixtures were designed to result in a master mix with a final volume of 10 Al/reaction containing 1 Â Universal PCR Master Mix (Applied Biosystems, Foster City, CA), 100 nM forward primer, 100 nM reverse primer, 1 nM probe, and 0.025% BSA. For the assay, 1 Al of extracted DNA sample was added to 10 Al of PCR mixture in each reaction capillary. A no-template control received 10 Al of reaction mixture with 1 Al of water. All capillaries were then sealed and centrifuged using an LC Carousel Centrifuge (Roche Molecular Biochemicals, Indianapolis, IN) to facilitate mixing. All PCR reactions were carried out using a LightCycler System (Roche Molecular Biochemicals). The thermal cycling conditions were 10 min at 95 -C and 40 cycles of 15 s at 95 -C and 1 min at 60 -C.
Car binding assay
The CHO and A549 cell lines (2 Â 10 5 cells in 100 Al of medium) were incubated at 4 -C with shaking using 100 Al of buffer alone or using 100 Al of buffer containing 2.5 Ag/ mL recombinant Ad5 fiber knob. After 1 h, viruses were added directly (at a multiplicity of infection of 5000 i.f.u./ cell, based on TaqMan real-time PCR E4 DNA copy numbers). Following shaking for another hour at 4 -C, the cells were washed three times with 1% BSA/PBS buffer, collected for total DNA preparation, and then quantitated using TaqMan real-time PCR with E4 primers as described above.
Cell killing assay
Five thousand 911 cells were plated overnight into each well of 96-well tissue culture plates in 100 Al of DMEM medium without phenol red containing 5% FBS. The cells were infected with Ad-wt-dE3, Ad-wt-E3-TK, and Ad-wtpIX-TK (at 1.0, 0.1, and 0.01 infectious units/cell) using replicates of three wells and three wells of non-infected cells as a control. At 12 h post-infection, GCV was added to the cells at increasing concentrations (0.125, 0.5, and 1.0 mM). Cell killing was measured by MTS assay (Promega, Madison, WI) at 4 days post-infection. Results were calculated as percent of non-infected cells with blank values (medium only) subtracted.
pIX-TK conversion assay
Conversion of [
3 H]-thymidine in vitro was analyzed by a modified version of a previously reported protocol (Gerber and Folkers, 1996) . Triple sets of reaction mixtures containing 50 mM Tris (pH 7.2), 5 mM ATP, 5 mM MgCl 2 , 2 mg/mL BSA, and 1 mM of [ 3 H]-thymidine (SigmaAldrich, St. Louis, MO), in a final volume of 330 Al, were incubated at 37 -C with increasing amount of purified Adwt-pIX-TK (0, 1.6 Â 10 9 , 8 Â 10 9 , and 3.2 Â 10 10 v.p.). Three corresponding blank reactions were performed using 1 mM unlabeled thymidine. Equivalent reactions were performed using purified Ad-wt-E3-TK (1.26 Â 10 10 v.p.) as negative controls. After 40 min, the reaction mixtures were inactivated by heating to 95 -C for 3 min followed by centrifugation for 1 min at 14,000 Â g. For determination of the total amount of [ 3 H]-labeled thymidine converted to its phosphorylated form, a DEAE-cellulose binding assay was performed. Three triplicates of 10 Al from each reaction mixture were transferred onto 200 Al DEAE-cellulose (buffered with 100 mM Tris, pH 7.2) and mixed by vortexing in order to bind the negatively charged phosphorylated thymidine. After binding, the mixtures were centrifuged and washed two times with 4 mM ammonium acetate and once with methanol to remove the nonphosphorylated thymidine. The cellulose pellets were transferred directly into scintillation vials containing 8 ml of scintillation cocktail and the amount of converted [ 3 H]-thymidine was determined using a scintillation counter. Results were calculated as percent total conversion using the amount of total labeled substrate obtained from sets of 10 Al triplicates from each reaction mixture pipetted directly into scintillation vials containing 8 ml of scintillation cocktail and counted.
MicroPET scan of Ad-infected HEK293 cells
PET studies were performed using a microPET rodent four-ring system (model R4) from CTI Concorde Microsystems, LLC (Knoxville, TN). In brief, the system operates in three dimensions and is composed of 6144 lutetium oxyorthosilicate crystal (LSO) detector elements, with a 7.8 cm axial and a 10 cm transaxial field-of-view. The 9-[4-[ 18 F]-fluoro-3-(hydroxymethyl)butyl]guanine analog ([ 18 F]-FHBG) has been used as a reporter probe to image the expression of the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) reporter gene in living organisms and has been suggested to be a more effective probe for in vivo imaging than other acycloguanosine analogs (Alauddin et al., 2004) . The HSV-1 TK phosphorylates [
18 F]-FHBG to its monophosphate form, leading to intracellular accumulation (Green et al., 2002) . Cellular retention of radioactivity is, therefore, an indicator of HSV-1 TK gene expression. Synthesis and purification of [
18 F]-FHBG have been described previously (Parks, 2005) .
For in vitro experiments, three 60-mm tissue culture dishes (Costar, Corning, NY) were plated for 12 h previously with 1 Â 10 6 of the HEK293 cell line in 3 ml of complete medium. On the day of microPET scanning, to each of the dishes was added 50 mCi of [
18 F]-FHBG. Immediately thereafter, to one plate was added 1 Â 10 9 v.p. (1.1 Â 10 7 i.f.u.) of Ad-wt-pIX-TK, to a second dish was added 1 Â 10 9 v.p. (1.9 Â 10 6 i.f.u.) of the control Ad-wtdE3 virus, and to a third dish was added PBS alone. The plates were incubated for 1 h at 37 -C, followed by three washes with 5 ml of PBS. The three dishes were stacked and placed in the microPET scanner, and image data were acquired for 15 min. MicroPET images were reconstructed by using an iterative reconstruction technique.
To confirm these results, three 60-mm tissue culture dishes (Costar, Corning, NY) were plated for 12 h previously with 1 Â 10 6 of the HEK293 cell line in 3 ml of complete medium. At 12 h after plating, one dish was infected with 1 Â 10 9 v.p. (1.1 Â 10 7 i.f.u.) of Ad-wt-pIX-TK. Likewise, at 36 h after plating, one dish was infected with an equivalent amount of Ad-wt-pIX-TK. A third dish remained uninfected. At 60 h after plating (48 h, 24 h, and 0 h post-infection with Ad-wt-pIX-TK), 50 mCi of [
18 F]-FHBG was added to each of the dishes. The plates were incubated for 1 h at 37 -C, followed by three washes with 5 mL of PBS. The three dishes were stacked and placed in the microPET scanner, and image data were acquired for 15 min. MicroPET images were reconstructed by using an iterative reconstruction technique.
